Sonneveld, P <br/><br/>
Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.  [electronic resource] 

 -  Leukemia  Nov 1996 
 - 1741-50 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--biosynthesis<br/>Administration, Oral<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cohort Studies<br/>Cyclosporins--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Vincristine--administration & dosage